Clinical pharmacy services and hospital mortality rates

Pharmacotherapy

Volumn 19, Issue 5, 1999, Pages 556-564

  Bond, C A ^a   Raehl, Cynthia L ^a   Franke, Todd ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DATA BASE; DISEASE SEVERITY; DRUG INFORMATION; HOSPITAL CARE; MORTALITY; PHARMACEUTICAL CARE; PHARMACY; REGRESSION ANALYSIS; RESUSCITATION; UNITED STATES;

EID: 0032925512     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.8.556.31531     Document Type: Article

References (60)

1. American College of Clinical Pharmacy. Vision statement. ACCP Rep 1997;16(10):S1-8.
2. Black BL. Resource book on progressive pharmaceutical services. Bethesda, MD: American Society of Hospital Pharmacists, 1986.
3. Hatoum HT, Catizone C, Hutchinson RA, et al. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
4. Comptroller General of the United States. Study of health facilities construction costs. Washington, DC: U.S. Government Printing Office, 1972:68-72, 363-79.
5. Barker KN, Pearson RE. Medication distribution systems. In: Brown TR, Smith MC, eds. Handbook of institutional pharmacy practice. Baltimore: Williams & Wilkins, 1986:325-51.
6. Elenbaas RM, Payne VW, Bauman JL. Influence of clinical pharmacists consultations on the use of blood level test. Am J Hosp Pharm 1980;37:61-4.
7. Bullish SJ, Kelly WN, Miller DE, et al. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital. Am J Hosp Pharm 1981;38:73-6.
8. Abramowitz PA, Nold EC, Hatfield SM. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm 1982;39:1176-80.
9. Mutchie KD, Smith KA, MacKay MW, et al. Pharmacists' monitoring of parenteral nutrition: clinical and cost effectiveness. Am J Hosp Pharm 1979;36:785-7.
10. Covinsky JO, Hamburger SC, Kelly KL, et al. Impact of docent clinical pharmacists on treatment of streptococcal pneumonia. Drug Intell Clin Pharm 1982;16:587-91.
11. Bond CA, Salinger RJ. Fluphenazine out-patient clinics: a pharmacist's role. J Clin Psychiatry 1979;40:501-3.
12. Herfindal ET, Bernstein LR, Kishi DT. Effect of clinical pharmacy services on prescribing on an orthopedic unit. Am J Hosp Pharm 1983;40:1945-51.
13. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63.
14. Knapp DE, Knapp DA, Speedie MK, et al. Relationship of inappropriate drug prescribing to increased length of hospital stay. Am J Hosp Pharm 1979;36:1334-7.
15. Knapp DE, Speedie MK, Yaeger DM, et al. Drug prescribing and its relationship to length of hospital stay. Inquiry 1980;17:254-9.
16. McKenney JM, Wasserman AH. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions. Am J Hosp Pharm 1979;36:1691-7.
17. Clapham CE, Hepler CE, Reinders TP, et al. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988;45:2329-40.
18. Bjornson DC, Hiner WO, Potyk RP, et al. Effect of pharmacist on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
19. Jenkins MH, Bond CA, The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy 1996;16(4):708-14.
20. Monson RA, Bond CA, Schuna A. Role of the clinical pharmacist in improving outpatient drug therapy. Arch Intern Med 1981;141:1441-4.
21. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control - a four year ambulatory care model. Arch Intern Med 1984;144:1159-62.
22. Tang I, Vrahnos D, Hatoum H, et al. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993;15:459-64.
23. Brown WJ. Pharmacist participation on a multidisciplinary rehabilitation team. Am J Hosp Pharm 1994;51:91-2.
24. Garber AM, Fuchs VR, Silverman JF. Case mix, costs, and outcomes: between faculty and community services in a university hospital. N Engl J Med 1984;310:1231-7.
25. Pauly MV, Wilson P. Hospital output forecasts and the cost of empty hospital beds. Health Serv Res 1986;21:413-28.
26. Rich EC, Gifford G, Luxenberg M, et al. The relationship of hospital staff experiences to the cost and quality of inpatient care. JAMA 1990;263:953-7.
27. Watts CA, Klastorin TD. The impact of case-mix on hospital costs: a comparative analysis. Inquiry 1990;17:357-67.
28. Boyko WL, Yurkowski PJ, Ivey M, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health-Syst Pharm 1997;54:1591-5.
29. Pitterle ME, Bond CA, Raehl CL, Franke T. Hospital and pharmacy characteristics associated with mortality rates in United States hospitals. Pharmacotherapy. 1994;14(5):620-30.
30. Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999;19(2):130-8.
31. Carter JH, Mills AC, Homan SM, et al. Correlating the quality of care with nursing resources and patient parameters: a longitudinal study. NLN Publ 20-2191,1987:331-45
32. Kelly JV, Hellinger FJ. Physician and hospital factors associated with mortality of surgical patients. Med Care 1986;24:785-800.
33. Rhee SO. Factors determining the quality of physician performance in patient care. Med Care 1976;14:733-50.
34. Shortell SM, Hughes EFX. The effects of regulation, competition, and ownership on mortality rates among hospital inpatients. N Engl J Med 1988;318:1100-7.
35. Dubois RW, Brooks RH, Rodgers WH. Adjusted hospital death rates; a potential screen quality of medical care. Am J Public Health 1987;77:1162-7.
36. Krakauer H, Bailey RC, Skellan KJ, Stewart JD, Hartz AJ. Evaluation of the HCFA model for the analysis of mortality following hospitalization. Health Serv Res 1992;27(3):317-35.
37. Hartz AJ, Gottlieb M, Kuhn ER, Rimm A. National validation study of Medicare mortality studies (project 1247-M). Technical report to the Health Standards and Quality Review Bureau. Washington, DC, 1989.
38. Hartz AJ, Krakauer H, Kuhn EM, et al. Hospital characteristics and mortality rates. N Engl J Med 1989;321:1720-5.
39. Keeler EB, Rubenstein LV, Kahn KL, et al. Hospital characteristics and quality of care. JAMA 1992;268:1709-14.
40. Green J, Wintfield N, Sharkey P, Passman LJ. The importance of severity of illness measures in assessing hospital mortality. JAMA 1990;262:241-6.
41. Green J, Passman LJ, Wintfield N. Analyzing hospital mortality - the consequences of diversity in patient mix. JAMA 1991;265:1849-53.
42. Bond CA, Raehl CL, Pitterle ME. 1992 National Clinical Pharmacy Services study. Pharmacotherapy 1994;14(3):282-304.
43. Health Care Financing Administration. Medicare hospital mortality information on data tape. Washington, DC: U.S. Government Printing Office, 1992.
44. Health Care Financing Administration. Medicare hospital mortality information, 1991. Washington, DC: U.S. Government Printing Office, 1992.
45. Raehl CL, Bond CA, Pitterle ME, Hospital pharmacy services in the Great Lakes region. Am J Hosp Pharm 1990;47: 1283-1303.
46. Raehl CL, Bond CA, Pitterle ME. Pharmaceutical services in U.S. hospitals in 1989. Am J Hosp Pharm 1992;49:323-46.
47. American Hospital Association. American Hospital Association abridged guide to the health care field data tape. Chicago: Author, 1992.
48. SAS Institute Inc. SAS, version 6.11. Cary, NC: Author, 1996.
49. Wampole BE, Freund RD. Use of multiple regression in counseling psychology research: a flexible data analytic strategy. J Counsel Psychol 1987;34:372-82.
50. Pedhazur EJ. Multiple regression in behavioral research: explanation and prediction, 2nd ed. New York: Harcourt Brace Jovanonich, 1982.
51. Greenfield S, Aronow HU, Elashoff RM, Watanaabe D. Flaws in mortality data: hazards of ignoring comorbid disease. JAMA 1988;260:2253-5.
52. Kenlel P. Hospitals balk at mortality report results. Modern Healthcare January 1, 1988:5-6.
53. American Hospital Association. Hospital statistics, 1992. Chicago: Author, 1993.
54. Rosenthal GE, Harper DL, Quinn LM, Cooper GS. Severity-adjusted mortality and length of stay in leaching hospitals and nonteaching hospitals: results of a regional study. JAMA 1997;278:485-90.
55. Pitterle ME, Bond CA, Raehl CL. Pharmaceutical care index measuring comprehensive pharmaceutical care. Am J Hosp Pharm 1992;46:2226-9.
56. Bond CA, Raehl CL, Pitterle ME. Cost of pharmaceutical services in U.S. hospitals in 1992. Am J Hosp Pharm 1995;52:603-13.
57. Leape LL, Bates DW, Cullen DJ, et al. System analysis of adverse drug events. JAMA 1995;274:35-43.
58. Johnson JA, Bootman JL. Drug related morbidity and mortality. Arch Intern Med 1995;155:1949-56.
59. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events JAMA 1995; 274:29-34.
60. Daley J, Jencks S, Draper D, et al. Predicting hospital-associated mortality for Medicare patients. JAMA 1988; 260:3617-24.